Moniek P. M. De Maat
Department for Thrombosis Research
University of Southern Denmark
Esbjerg
Denmark
Name/email consistency: high
- Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy. de Maat, M.P., Madsen, J.S., Langdahl, B., Bladbjerg, E.M., Tofteng, C.L., Abrahamsen, B., Rejnmark, L., Brixen, K., Christensen, K., Jespersen, J., Kristensen, S.R. Thromb. Haemost. (2007)
- Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis. de Maat, M.P., Bladbjerg, E.M., Kluft, C., Winkler, U.H., Rekers, H., Skouby, S.O., Jespersen, J. Hum. Reprod. (2006)
- Fibrinogen heterogeneity: inherited and noninherited. de Maat, M.P., Verschuur, M. Curr. Opin. Hematol. (2005)
- Preeclampsia and its interaction with common variants in thrombophilia genes. De Maat, M.P., Jansen, M.W., Hille, E.T., Vos, H.L., Bloemenkamp, K.W., Buitendijk, S., Helmerhorst, F.M., Wladimiroff, J.W., Bertina, R.M., De Groot, C.J. J. Thromb. Haemost. (2004)
- Genetic influence on inflammation variables in the elderly. de Maat, M.P., Bladbjerg, E.M., Hjelmborg, J.B., Bathum, L., Jespersen, J., Christensen, K. Arterioscler. Thromb. Vasc. Biol. (2004)
- C-reactive protein as a risk factor versus risk marker. de Maat, M.P., Trion, A. Curr. Opin. Lipidol. (2004)